| 1 |
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al. · New England Journal of Medicine
Open access |
18 Jul 2011 |
7,006 |
| 2 |
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant et al. · New England Journal of Medicine
Open access |
23 Nov 2010 |
5,186 |
| 3 |
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
Raimunda do Socorro da Silva Azevedo, Jorge Rodrigues de Sousa, Marialva Tereza Ferreira de Araújo et al. · Scientific Reports
Open access |
2 Jan 2018 |
3,563 |
| 4 |
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Myron S. Cohen et al. · New England Journal of Medicine
Open access |
18 Jul 2016 |
1,760 |
| 5 |
Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples
Joshua C Quick et al. · Nature Protocols
Open access |
24 May 2017 |
1,344 |
| 6 |
Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study
Guilherme Amaral Calvet, Renato Santana Aguiar, Adriana Melo et al. · The Lancet Infectious Diseases
Open access |
19 Feb 2016 |
1,195 |
| 7 |
Zika virus in the Americas: Early epidemiological and genetic findings
Nuno Rodrigues Faria et al. · Science
Open access |
25 Mar 2016 |
1,142 |
| 8 |
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J. Landovitz et al. · New England Journal of Medicine
Open access |
11 Aug 2021 |
913 |
| 9 |
Origins of Dengue Type 2 Viruses Associated with Increased Pathogenicity in the Americas
Rebeca Rico-Hesse, Lisa Marie Harrison, Rosa Alba Salas et al. · Virology
Open access |
Apr 1997 |
693 |
| 10 |
Yellow fever
Thomas P. C. Monath, Pedro Fernando da Costa Vasconcelos · Journal of Clinical Virology
Open access |
24 Oct 2014 |
688 |
| 11 |
Establishment and cryptic transmission of Zika virus in Brazil and the Americas
Nuno Rodrigues Faria et al. · Nature
Open access |
23 May 2017 |
676 |
| 12 |
Emergence and potential for spread of Chikungunya virus in Brazil
Márcio Roberto Teixeira Nunes et al. · BMC Medicine
Open access |
30 Apr 2015 |
548 |
| 13 |
Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review
R. Lainson, Elizabeth Ferreira Rangel · Memórias do Instituto Oswaldo Cruz
Open access |
Dec 2005 |
544 |
| 14 |
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir et al. · New England Journal of Medicine
Open access |
19 Oct 2011 |
542 |
| 15 |
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Pedro Enrique Cahn et al. · The Lancet
Open access |
3 Jul 2013 |
518 |
| 16 |
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial
José Valdez Madruga, Pedro Enrique Cahn, Beatriz Gilda Jegerhorn Grinsztejn et al. · The Lancet
|
Jul 2007 |
517 |
| 17 |
Mpox in people with advanced HIV infection: a global case series
Oriol Mitjà et al. · The Lancet
Open access109 authors |
21 Feb 2023 |
516 |
| 18 |
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Gilda Jegerhorn Grinsztejn et al. · The Lancet Infectious Diseases
Open access |
4 Mar 2014 |
516 |
| 19 |
The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis
Kyung Joo Kwon-Chung et al. · mSphere
Open access |
11 Jan 2017 |
422 |
| 20 |
Zika virus and microcephaly: why is this situation a PHEIC?
David L Heymann, Abraham Hodgson, Amadou Alpha Sall et al. · The Lancet
Open access |
Feb 2016 |
417 |
| 21 |
Taxonomy of the order Bunyavirales: update 2019
Abulikemu Abudurexiti et al. · Archives of Virology
Open access103 authors |
7 May 2019 |
406 |
| 22 |
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
Jean‐Michel Molina, Pedro Enrique Cahn, Beatriz Gilda Jegerhorn Grinsztejn et al. · The Lancet
|
Jul 2011 |
404 |
| 23 |
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World
Luiz Fernando Ganassali de Oliveira Júnior, Armando O. Schubach, Maria M. Martins et al. · Acta Tropica
ReviewOpen access |
9 Apr 2011 |
393 |
| 24 |
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study
Alexandre C. Linhares, F. Raúl Velázquez, Irene Pérez‐Schael et al. · The Lancet
|
Apr 2008 |
379 |
| 25 |
Infectiousness in a Cohort of Brazilian Dogs: Why Culling Fails to Control Visceral Leishmaniasis in Areas of High Transmission
Orin Courtenay, Rupert J. Quinnell, Lourdes Maria Garcez et al. · The Journal of Infectious Diseases
Open access |
15 Oct 2002 |
379 |
| 26 |
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
Susan Swindells et al. · New England Journal of Medicine
Open access |
13 Mar 2019 |
378 |
| 27 |
Vesicular transport inHistoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes
Priscila Costa Albuquerque, Ernesto Satoshi Nakayasu, Márcio Lourenço Rodrigues et al. · Cellular Microbiology
Open access |
18 Apr 2008 |
357 |
| 28 |
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation
Eugênio Damaceno Hottz, Juliana Freitas Lopes, Carla Santos de Freitas et al. · Blood
Open access |
5 Sep 2013 |
353 |
| 29 |
What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)?
Steven Michael Goodreau, Nicole Bohme Carnegie, Eric Vittinghoff et al. · PLoS ONE
Open access |
29 Nov 2012 |
348 |
| 30 |
Emerging Chagas disease in Amazonian Brazil
José Rodrigues Coura, Ângela Cristina Veríssimo Junqueira, Octávio Fernandes et al. · Trends in Parasitology
Review |
Apr 2002 |
328 |
| 31 |
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Suelen da Silva Gomes Dias et al. · PLoS Pathogens
Open access |
16 Dec 2020 |
325 |
| 32 |
Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis
Cássia Righy, Régis Goulart Rosa, Rodrigo Teixeira Amancio da Silva et al. · Critical Care
ReviewOpen access |
11 Jun 2019 |
325 |
| 33 |
COVID-19 and the cardiovascular system
Andrea De Lorenzo, Cristiane da Cruz Lamas · Heart Vessels and Transplantation
Open access |
22 May 2020 |
324 |
| 34 |
Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected Orthobunyavirus
J. F. Travassos da Rosa, William Marciel de Souza, Francisco de Paula Pinheiro et al. · American Journal of Tropical Medicine and Hygiene
Open access |
6 Feb 2017 |
308 |
| 35 |
Guillain-Barré syndrome associated with Zika virus infection
Patrícia Brasil, Patrícia Carvalho de Sequeira, Andrea D’Ávila Freitas et al. · The Lancet
Open access |
Apr 2016 |
300 |
| 36 |
2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
Jens H. Kuhn et al. · Archives of Virology
Open access229 authors |
4 Sep 2020 |
298 |
| 37 |
Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil
Michael A. Miles, Adelson Alcimar Almeida de Souza, Marinete Marins Póvoa et al. · Nature
Open access |
Apr 1978 |
295 |
| 38 |
Evaluation of anti-tubercular activity of nicotinic and isoniazid analogues
Maria Cristina S. Lourenço, M.V.N. De Souza, Alessandra Campbell Pinheiro et al. · ARKIVOC
Open access |
11 Oct 2007 |
289 |
| 39 |
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases
Pedro FC Vasconcelos et al. · The Lancet
Open access |
Jul 2001 |
286 |
| 40 |
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
Colleen Frances Kelley et al. · New England Journal of Medicine
|
27 Nov 2024 |
285 |
| 41 |
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
André Costa Ferreira, Vinícius Cardoso Soares, Isaclaudia Gomes de Azevedo-Quintanilha et al. · Cell Death Discovery
Open access |
Mar 2021 |
281 |
| 42 |
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Justin M. Richner et al. · Cell
Open access |
Jul 2017 |
275 |
| 43 |
II Consenso Brasileiro em Doença de Chagas, 2015
João Carlos Pinto Dias et al. · Epidemiologia e Serviços de Saúde
Open access |
Jun 2016 |
270 |
| 44 |
Co-distribution and co-infection of chikungunya and dengue viruses
Luis Furuya‐Kanamori, Shaohong Liang, Gabriel J. Milinovich et al. · BMC Infectious Diseases
Open access |
17 Feb 2016 |
265 |
| 45 |
Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum
Philippe Dussart, Bhety Labeau, Gisèle Lagathu et al. · Clinical and Vaccine Immunology
Open access |
Nov 2006 |
253 |
| 46 |
Dynamics of dengue virus circulation: a silent epidemic in a complex urban area
Maria Glória Teixeira, Maurício L. Barreto, Maria da Conceição Nascimento Costa et al. · Tropical Medicine & International Health
|
Sep 2002 |
253 |
| 47 |
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
Ana Espinel‐Ingroff et al. · Antimicrobial Agents and Chemotherapy
Open access |
5 Sep 2012 |
252 |
| 48 |
The American leishmaniases: some observations on their ecology and epidemiology
R. Lainson · Transactions of the Royal Society of Tropical Medicine and Hygiene
Open access |
1983 |
252 |
| 49 |
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
Maria Alice Freitas Queiroz et al. · Frontiers in Cellular and Infection Microbiology
Open access |
30 Jun 2022 |
249 |
| 50 |
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures
Margaret Johnson, Beatriz Gilda Jegerhorn Grinsztejn, Claudia Rodríguez et al. · AIDS
|
8 Apr 2005 |
249 |